Angela Zhou

Angela Zhou, Information Scientist at CAS

Angela Zhou is an Information Scientist at CAS. She earned her Ph.D. in Molecular Pharmacology and toxicology from University of Southern California. She was further trained as a cell biologist at Johns Hopkins School of Medicine and worked in the area of cancer biology at Harvard Medical School. She was a faculty member at Missouri State University and Denison University prior to joining CAS.

Manager of Scientific Analysis and Insights, CAS

Angela Zhou is an Information Scientist at CAS. She earned her Ph.D. in Molecular Pharmacology and toxicology from University of Southern California. She was further trained as a cell biologist at Johns Hopkins School of Medicine and worked in the area of cancer biology at Harvard Medical School. She was a faculty member at Missouri State University and Denison University prior to joining CAS.

GettyImages-1415655606_CAS-Insights-Hero-Image

The gut microbiome is a complex ecosystem of trillions of bacteria that live in our digestive tracts with health benefits like immunity, improved mental health, and therapeutic options. In recent years, there has been a growing interest in the potential of microbiome therapies to treat a variety of diseases. As our understanding of the gut microbiome continues to grow, we can expect to see more advances in microbiome therapies in the years to come.

| Article

Targeting a Potentially Important Receptor in Disease Pathogenesis

Learn more about ACE2 the critical protein that remains the critical target of COVID-19 and so many additional viral infections. This overviews emerging trends and insights on publications, milestones, and future applications to target ACE2 proteins.

| Article

Load More